(2010). Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: The pan-american collaborative retina study.
Chicago Style (17th ed.) CitationIntravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration at Twenty-four Months: The Pan-american Collaborative Retina Study. 2010.
MLA (8th ed.) CitationIntravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration at Twenty-four Months: The Pan-american Collaborative Retina Study. 2010.
Warning: These citations may not always be 100% accurate.